Intravitreal Dexamethasone Implant (Ozurdex) to Control Recurrent Severe Idiopathic Uveitis Leads to Improvement in Steroid-Induced Diabetes Mellitus

Ashraf A. KhanPrincess Alexandra Eye Pavilion, Edinburgh, UKCorrespondence[email protected]

, MBChB, FRCOphth,

Georgios KontosPrincess Alexandra Eye Pavilion, Edinburgh, UK

, MSc,

Sheila P. Paterson-BrownPrincess Alexandra Eye Pavilion, Edinburgh, UK

, MBBS, MRCP, MRCGP, DRCOG, DRCOphth &

Baljean DhillonPrincess Alexandra Eye Pavilion, Edinburgh, UK

, BMedSci (Hons), BMBS, FRCPS, FRCPE, FRCSEd, FRCOphth

REFERENCES

Hwang JL, Weiss RE. Steroid-induced diabetes: a clinical and molecular approach to understanding and treatment. Diabetes Metab Res Rev. 2014. 30(2):96–102.
PubMed Web of Science ®Google Scholar
Kurir TT, Bozić J, Markotić A, et al. [New insights in steroid diabetes]. Acta Med Croatica. 2012;66(4):303–310.
PubMedGoogle Scholar
Schmitz K, Maier M, Clemens CR, et al. [Reliability and safety of intravitreal Ozurdex injections. The ZERO study]. Ophthalmologe. 2014;111(1):44–52.
PubMed Web of Science ®Google Scholar
Guigou S, Pommier S, Meyer F, et al. Efficacy and safety of intravitreal dexamethasone implant in patients with diabetic macular edema. Ophthalmologica. 2015; 233 (3–4): 169–175.
PubMed Web of Science ®Google Scholar
Tomkins-Netzer O, Taylor SR, Bar A, et al. Treatment with repeat dexamethasone implants results in long-term disease control in eyes with noninfectious uveitis. Ophthalmology. 2014; 121(8):1649–1654.
PubMed Web of Science ®Google Scholar
Konig M, Lamos EM, Stein SA, et al. An insight into the recent diabetes trials: what is the best approach to prevent macrovascular and microvascular complications? Curr Diabetes Rev. 2013;9(5): 371–381.
PubMedGoogle Scholar
Writing Group for the DCCT/EDIC Research Group, Orchard TJ, Nathan DM, et al. Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality. JAMA. 2015;313(1):45–53.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Intravitreal Dexamethasone Implant (Ozurdex) to Control Recurrent Severe Idiopathic Uveitis Leads to Improvement in Steroid-Induced Diabetes Mellitus

REFERENCES

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intravitreal Dexamethasone Implant (Ozurdex) to Control Recurrent Severe Idiopathic Uveitis Leads to Improvement in Steroid-Induced Diabetes Mellitus

REFERENCES

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date